All In Biotech

Drug Trial Radar · NCT06935370

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

EASi-HF Reduced - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Symptomatic Chronic Heart Failure (HF: NYHA II-IV) and Left Ventricular Ejection Fraction (LVEF) < 40%

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 4,200 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

4,200

Planned (sponsor's estimate)

Start

May 20, 2025

Primary completion

Feb 4, 2029

Study completion Feb 22, 2029

Sponsor

Lead sponsor
Boehringer IngelheimBoehringer Ingelheim
Sponsor type
Industry
First posted
Apr 20, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the study if they have been diagnosed with chronic HF at least 3 months before they start on the study. The purpose of this study is to find out whether a medicine called vicadrostat, in combination with another medicine called empagliflozin, helps people with chronic heart failure. In this study, participants are put into 2 groups randomly. Participants have an equal chance of being in either group. One group takes vicadrostat/empagliflozin tablets, and the other group takes placebo/empagliflozin tablets. Placebo tablets look like vicadrostat tablets but do not contain any medicine. Participants take the study medicines as tablets once a day for between about 6 months and about 3.5 years. During this time, they can continue their regular treatment for heart failure. Participants can stay in the study as long as they benefit from treatment and can tolerate it, for a maximum of about 3.5 years. During this time, they visit the study site regularly. The exact number of visits is different for each participant, depending on how long they stay in the study. The study staff may also contact the participants by phone for some visits. Participants also regularly answer questions about their well-being. The doctors document when participants experience worsening of their heart failure symptoms, go to hospital due to heart failure or die during the study. The time until these events are observed is compared between the two treatment groups to see whether the treatment works. The doctors also regularly check participants' health and take note of any unwanted effects.

Conditions

  • Heart Failure

Interventions

  • vicadrostatDrug

    vicadrostat

  • empagliflozinDrug

    empagliflozin

  • PlaceboDrug

    Placebo matching vicadrostat

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to first event of Cardiovascular (CV) death, or Hospitalisation for heart failure (HHF), or Urgent heart failure (HF) visitTime frame: up to 43 months

Locations

596 sites in 29 countries. Site status is shown where the registry gives one.

  • Cure Clinical Research

    Beverly Hills, California · Suspended

  • Valley Clinical Trials, Inc.

    Covina, California · Recruiting

  • North Coast Cardiology

    Encinitas, California · Not yet recruiting

  • Merced Vein and Vascular Center

    Merced, California · Recruiting

  • Radin Cardiovascular Medical Group

    Newport Beach, California · Recruiting

  • Amicis Research Center - Nordhoff

    Northridge, California · Terminated

  • University of California San Diego

    San Diego, California · Not yet recruiting

  • Paradigm Clinical Research - San Diego

    San Diego, California · Recruiting

  • Amicis Research Corporate

    Santa Clarita, California · Terminated

  • Care Access Research

    Thousand Oaks, California · Recruiting

  • Bay Area Cardiology

    Brandon, Florida · Suspended

  • Cardiology Associates Research Co.

    Daytona Beach, Florida · Recruiting

  • Suncoast Research Associates, LLC

    Doral, Florida · Recruiting

  • Malcom Randall VA Medical Center

    Gainesville, Florida · Recruiting

  • Velocity Clinical Research-Hallandale Beach-67888

    Hallandale, Florida · Recruiting

  • University of Florida

    Jacksonville, Florida · Recruiting

  • East Coast Institute For Research, LLC

    Jacksonville, Florida · Recruiting

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida · Recruiting

  • University of Miami - Miller School of Medicine

    Miami, Florida · Recruiting

  • Infinite Clinical Research Inc

    Miami, Florida · Recruiting

  • Inpatient Research Clinic, LLC

    Miami Lakes, Florida · Recruiting

  • Innovation Medical Research Center

    Palmetto Bay, Florida · Recruiting

  • Peace River Cardiovascular Center

    Port Charlotte, Florida · Recruiting

  • St. Johns Center for Clinical Research

    Saint Augustine, Florida · Recruiting

  • University of South Florida

    Tampa, Florida · Recruiting

  • Cardiology Partners Clinical Research Institute

    Wellington, Florida · Recruiting

  • Cozy Research LLC

    Wesley Chapel, Florida · Recruiting

  • Flourish Research

    Winter Park, Florida · Recruiting

  • Atlanta Clinical Research Centers

    Atlanta, Georgia · Recruiting

  • NSC Research Inc

    Johns Creek, Georgia · Recruiting

  • Northwest Heart Clinical Research, LLC

    Arlington Heights, Illinois · Not yet recruiting

  • Chicago Medical Research

    Hazel Crest, Illinois · Recruiting

  • Clinical Investigation Specialists, Inc.

    Libertyville, Illinois · Recruiting

  • AMR Park Ridge

    Park Ridge, Illinois · Recruiting

  • Springfield Clinic

    Springfield, Illinois · Recruiting

  • Midwest Cardiovascular Research and Education Foundation

    Elkhart, Indiana · Recruiting

  • St. Francis Medical Group-Indiana Heart Physicians, Inc

    Indianapolis, Indiana · Recruiting

  • Indiana Medical Research Institute

    Merrillville, Indiana · Recruiting

  • Cardiovascular Research of Northwest Indiana, LLC

    Munster, Indiana · Recruiting

  • Reid Hospital

    Richmond, Indiana · Recruiting

Showing 40 of 596 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.